Long non-coding RNA HOXD-AS1 in cancer.
In conclusion, HOXD-AS1 may be considered as a promising diagnostic/prognostic biomarker or a novel therapeutic target for cancers.
PMID: 30290157 [PubMed - as supplied by publisher]
Source: International Journal of Clinical Chemistry - Category: Chemistry Authors: Li L, Wang Y, Zhang X, Huang Q, Diao Y, Yin H, Liu H Tags: Clin Chim Acta Source Type: research
More News: Bladder Cancer | Bone Cancers | Brain Tumor | Cancer | Cancer & Oncology | Carcinoma | Cervical Cancer | Chemistry | Colorectal Cancer | Gastric (Stomach) Cancer | Gastroenterology | Genetics | Glioma | Hepatocellular Carcinoma | Liver Cancer | Lung Cancer | Melanoma | Non-Small Cell Lung Cancer | Osteosarcoma | Ovarian Cancer | Ovaries | Prostate Cancer | Skin Cancer
MedWorm Privacy Policy
Disclaimer
Copyright © MedWorm 2006-2024